Effect of amantadine hydrochloride on symptoms of frontal lobe dysfunction in brain injury: case studies and review



	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted
	Citation Map



	Email this article to a Colleague
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Add to My Articles & Searches
	Download to citation manager



	Citing Articles via HighWire
	Citing Articles via Google Scholar



	Articles by Kraus, M. F.
	Articles by Maki, P. M.
	Search for Related Content



	PubMed Citation
	Articles by Kraus, M. F.
	Articles by Maki, P. M.

J Neuropsychiatry Clin Neurosci 1997; 9:222-230
Copyright © 1997 by American Neuropsychiatric Association

REGULAR ARTICLES

Effect of amantadine hydrochloride on symptoms of frontal lobe dysfunction in brain injury: case studies and review

MF Kraus and PM Maki
Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.

Symptoms consistent with dysfunction of the frontal lobes can occur following traumatic brain injury (TBI) or other types of acquired brain injury (stroke, aneurysm). These symptoms can include problems with short-term memory, attention, planning, problem solving, impulsivity, disinhibition, poor motivation, and other behavioral and cognitive deficits ("frontal lobe syndrome"). These symptoms may respond to certain drugs, such as dopaminergic agents. This case series describes results of using amantadine in 7 patients with this type of symptom profile (6 with TBI, 1 with meningitis following sinus surgery). Patients received neuropsychiatric examinations and serial neuropsychological testing. All patients showed some degree of positive response. One had side effects that resolved upon discontinuation of drug. The rationale for using dopaminergics is discussed, and pertinent literature is reviewed.

This article has been cited by other articles:

S. Vaishnavi, V. Rao, and J. R. Fann
Neuropsychiatric Problems After Traumatic Brain Injury: Unraveling the Silent Epidemic
Psychosomatics, May 1, 2009; 50(3): 198 - 205.
[Abstract] [Full Text] [PDF]

R. G. Robinson, R. E. Jorge, K. Clarence-Smith, and S. Starkstein
Double-Blind Treatment of Apathy in Patients with Poststroke Depression Using Nefiracetam
J Neuropsychiatry Clin Neurosci, May 1, 2009; 21(2): 144 - 151.
[Abstract] [Full Text] [PDF]

V. Rao, S. Handel, S. Vaishnavi, S. Keach, B. Robbins, J. Spiro, J. Ward, and F. Berlin
Psychiatric Sequelae of Traumatic Brain Injury: A Case Report
Am J Psychiatry, May 1, 2007; 164(5): 728 - 735.
[Full Text] [PDF]

P. R. Padala, W. J. Burke, S. C. Bhatia, and F. Petty
Treatment of Apathy With Methylphenidate
J Neuropsychiatry Clin Neurosci, February 1, 2007; 19(1): 81 - 83.
[Abstract] [Full Text] [PDF]

R. van Reekum, D. T. Stuss, and L. Ostrander
Apathy: Why Care?
J Neuropsychiatry Clin Neurosci, February 1, 2005; 17(1): 7 - 19.
[Abstract] [Full Text] [PDF]

S. J. Drayton, K. Davies, M. Steinberg, I. Leroi, A. Rosenblatt, and C. G. Lyketsos
Amantadine for Executive Dysfunction Syndrome in Patients With Dementia
Psychosomatics, June 1, 2004; 45(3): 205 - 209.
[Abstract] [Full Text] [PDF]

C. G. Lyketsos, A. Rosenblatt, and P. Rabins
Forgotten Frontal Lobe Syndrome or "Executive Dysfunction Syndrome"
Psychosomatics, June 1, 2004; 45(3): 247 - 255.
[Full Text] [PDF]

H. F. Moselhy, G. Georgiou, and A. Kahn
FRONTAL LOBE CHANGES IN ALCOHOLISM: A REVIEW OF THE LITERATURE
Alcohol Alcohol., September 1, 2001; 36(5): 357 - 368.
[Abstract] [Full Text] [PDF]

Get information about faster international access.